In overall survival (Figure 4), low expression HOPX predicted good survival in AML, brain lower grade glioma, cervical squamous cell carcinoma and endocervical adenocarcinoma, colon adenocarcinoma, LUAD, lung squamous cell carcinoma, and STAD. The gene discussed is HOPX; the disease is gastric adenocarcinoma.